Overview

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and anti-Kaposi's sarcoma activity of ritonavir.
Phase:
Phase 2
Details
Lead Sponsor:
Abbott
Treatments:
Ritonavir